RIP1 links inflammatory and growth factor signaling pathways by regulating expression of the EGFR

Cell Death and Differentiation

Volumn 15, Issue 2, 2008, Pages 344-353

  Ramnarain, D B ^a   Paulmurugan, R ^b   Park, S ^a   Mickey, B E ^a,c   Asaithamby, A ^a   Saha, D ^a   Kelliher, M A ^d   Mukhopadhyay, P ^a   Banani, F ^a   Madden, C J ^a,c   Wright, P S ^a   Chakravarty, S ^c   Habib, A A ^a,c,e  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MUTANT PROTEIN; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN; RECEPTOR INTERACTING PROTEIN 1; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL NUCLEUS; CYTOPLASM; EMBRYO; ENZYME ACTIVATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE, TUMOR; CELL NUCLEUS; DNA; DOWN-REGULATION; HUMANS; MICE; MICE, KNOCKOUT; NF-KAPPA B; PROMOTER REGIONS (GENETICS); RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; RECOMBINANT PROTEINS; RNA, MESSENGER; SIGNAL TRANSDUCTION; SP1 TRANSCRIPTION FACTOR;

MUS;

EID: 38049120928     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4402268     Document Type: Article

References (42)

1. Balkwill F, Mantovani A. Inflammation and cancer: Back to Virchow? Lancet 2001; 357: 539-545.
2. Karin M, Greten FR. NF-kappaB: Linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 2005; 5: 749-759.
3. Blume-Jensen P, Hunter T. Oncogenic kinase signalling. Nature 2001; 411: 355-365.
4. Lollini PL, Cavallo F, Nanni P, Forni G. Vaccines for tumour prevention. Nat Rev Cancer 2006; 6: 204-216.
5. Meylan E, Tschopp J. The RIP kinases: Crucial integrators of cellular stress. Trends Biochem Sci 2005; 30: 151-159.
6. Stanger BZ, Leder P, Lee TH, Kim E, Seed B. RIP: A novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell 1995; 81: 513-523.
7. Festjens N, Vanden Berghe T, Cornelis S, Vandenabeele P. RIP1, a kinase on the crossroads of a cell's decision to live or die. Cell Death Differ 2007; 14: 400-410.
8. Hsu H, Huang J, Shu HB, Baichwal V, Goeddel DV. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 1996; 4: 387-396.
9. Ting AT, Pimentel-Muinos FX, Seed B. RIP mediates tumor necrosis factor receptor 1 activation of NF-kappaB but not Fas/APO-1-initiated apoptosis. EMBO J 1996; 15: 6189-6196.
10. Kelliher MA, Grimm S, Ishida Y, Kuo F, Stanger BZ, Leder P. The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. Immunity 1998; 8: 297-303.
11. Meylan E, Burns K, Hofmann K, Blancheteau V, Martinon F, Kelliher M et al. RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation. Nat Immunol 2004; 5: 503-507.
12. Hur GM, Lewis J, Yang Q, Lin Y, Nakano H, Nedospasov S et al. The death domain kinase RIP has an essential role in DNA damage-induced NF-kappa B activation. Genes Dev 2003; 17: 873-882.
13. Pimentel-Muinos FX, Seed B. Regulated commitment of TNF receptor signaling: A molecular switch for death or activation. Immunity 1999; 11: 783-793.
14. Johnson AC, Ishii S, Jinno Y, Pastan I, Merlino GT. Epidermal growth factor receptor gene promoter. Deletion analysis and identification of nuclear protein binding sites. J Biol Chem 1988; 263: 5693-5699.
15. Hudson LG, Santon JB, Gill GN. Regulation of epidermal growth factor receptor gene expression. Mol Endocrinol 1989; 3: 400-408.
16. Kageyama R, Merlino GT, Pastan I. Epidermal growth factor (EGF) receptor gene transcription. Requirement for Sp1 and an EGF receptor-specific factor. J Biol Chem 1988; 263: 6329-6336.
17. DiMario JX. Activation and repression of growth factor receptor gene transcription (Review). Int J Mol Med 2002; 10: 65-71.
18. Krappmann D, Hatada EN, Tegethoff S, Li J, Klippel A, Giese K et al The I kappa B kinase (IKK) complex is tripartite and contains IKK gamma but not IKAP as a regular component. J Biol Chem 2000; 275: 29779-29787.
19. Hudson LG, Thompson KL, Xu J, Gill GN. Identification and characterization of a regulated promoter element in the epidermal growth factor receptor gene. Proc Natl Acad Sci USA 1990; 87: 7536-7540.
20. Vallian S, Chin KV, Chang KS. The promyelocytic leukemia protein interacts with Sp1 and inhibits its transactivation of the epidermal growth factor receptor promoter. Mol Cell Biol 1998; 18: 7147-7156.
21. Micheau O, Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 2003; 114: 181-190.
22. Nishi H, Senoo M, Nishi KH, Murphy B, Rikiyama T, Matsumura Y et al p53 Homologue p63 represses epidermal growth factor receptor expression. J Biol Chem 2001; 276: 41717-41724.
23. Ludes-Meyers JH, Subler MA, Shivakumar CV, Munoz RM, Jiang P, Bigger JE et al. Transcriptional activation of the human epidermal growth factor receptor promoter by human p53. Mol Cell Biol 1996; 16 6009-6019.
24. Sheikh MS, Carrier F, Johnson AC, Ogdon SE, Fornace Jr AJ. Identification of an additional p53-responsive site in the human epidermal growth factor receptor gene promotor. Oncogene 1997; 15: 1095-1101.
25. Rubinstein YR, Proctor KN, Bergel M, Murphy B, Johnson AC. Interferon regulatory factor-1 is a major regulator of epidermal growth factor receptor gene expression. FEBS Lett 1998; 431: 268-272.
26. Nishi H, Nishi KH, Johnson AC. Early growth response-1 gene mediates up-regulation of epidermal growth factor receptor expression during hypoxia. Cancer Res 2002; 62: 827-834.
27. Englert C, Hou X, Maheswaran S, Bennett P, Ngwu C, Re GG et al. WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis. EMBO J 1995; 14: 4662-4675.
28. Prudenziati M, Sirito M, van Dam H, Ravazzolo R. Adenovirus E1A down-regulates the EGF receptor via repression of its promoter. Int J Cancer 2000; 88: 943-948.
29. Murata Y, Kim HG, Rogers KT, Udvadia AJ, Horowitz JM. Negative regulation of Sp1 trans-activation is correlated with the binding of cellular proteins to the amino terminus of the Sp1 trans-activation domain. J Biol Chem 1994; 269: 20674-20681.
30. Birbach A, Gold P, Binder BR, Hofer E, de Martin R, Schmid JA. Signaling molecules of the NF-kappa B pathway shuttle constitutively between cytoplasm and nucleus. J Biol Chem 2002; 277: 10842-10851.
31. Gomez-Angelats M, Cidlowski JA, Molecular evidence for the nuclear localization of FADD. Cell Death Differ 2003; 10: 791-797.
32. Screaton RA, Kiessling S, Sansom OJ, Millar CB, Maddison K, Bird A et al. Fas-associated death domain protein interacts with methyl-CpG binding domain protein 4: A potential link between genome surveillance and apoptosis. Proc Natl Acad Sci USA 2003; 100: 5211-5216.
33. Morgan M, Thorburn J, Pandolfi PP, Thorburn A. Nuclear and cytoplasmic shuttling of TRADD induces apoptosis via different mechanisms. J Cell Biol 2002; 157: 975-984.
34. Nishi H, Neta G, Nishi KH, Akers LM, Rikiyama T, Proctor KN et al. Analysis of the epidermal growth factor receptor promoter: The effect of nuclear factor-kappaB. Int J Mol Med 2003; 11: 49-55.
35. Tao YG, Tan YN, Liu YP, Song X, Zeng L, Gu HH et al. Epstein-Barr virus latent membrane protein 1 modulates epidermal growth factor receptor promoter activity in a nuclear factor kappa B-dependent manner. Cell Signal 2004; 16: 781-790.
36. Novotny-Smith CL, Zorbas MA, McIsaac AM, Irimura T, Boman BM, Yeoman LC et al. Down-modulation of epidermal growth factor receptor accompanies TNF-induced differentiation of the DiFi human adenocarcinoma cell line toward a goblet-like phenotype. J Cell Physiol 1993; 157: 253-262.
37. Kalthoff H, Roeder C, Brockhaus M, Thiele HG, Schmiegel W. Tumor necrosis factor (TNF) up-regulates the expression of p75 but not p55 TNF receptors, and both receptors mediate, independently of each other, up-regulation of transforming growth factor alpha and epidermal growth factor receptor mRNA. J Biol Chem 1993; 268: 2762-2766.
38. Habib AA, Chatterjee S, Park SK, Ratan RR, Lefebvre S, Vartanian T. The epidermal growth factor receptor engages receptor interacting protein and nuclear factor-kappa B (NF-kappa B)-inducing kinase to activate NF-kappa B. Identification of a novel receptor-tyrosine kinase signalosome. J Biol Chem 2001; 276: 8865-8874.
39. Wajant H, Pfizenmaier K, Scheurich P. Tumor necrosis factor signaling. Cell Death Differ 2003; 10: 45-65.
40. Perkins ND, Gilmore TD. Good cop, bad cop: The different faces of NF-kappaB. Cell Death Differ 2006; 13: 759-772.
41. Janes KA, Gaudet S, Albeck JG, Nielsen UB, Lauffenburger DA, Sorger PK. The response of human epithelial cells to TNF involves an inducible autocrine cascade. Cell 2006; 124: 1225-1239.
42. Cusson N, Oikemus S, Kilpatrick ED, Cunningham L, Kelliher M. The death domain kinase RIP protects thymocytes from tumor necrosis factor receptor type 2-induced cell death. J Exp Med 2002; 196: 15-26.